BioSpace News Archive

Business

Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results

Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the third quarter ended September 30, 2023.

November 14, 2023
·
8 min read
BioMidwest

Fortress Biotech Announces Closing of $10.0 Million Public Offering

Fortress Biotech, Inc. announced the closing of its previously announced public offering of an aggregate of 5,885,000 units, consisting of one share of common stock and one warrant to purchase one share of common stock, at a public offering price of $1.70 per unit.

November 14, 2023
·
5 min read
Business

Onconova Therapeutics Reports Corporate Update and Announces Third Quarter 2023 Financial Results

Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today reported third quarter 2023 financial results and provided an update on recent pipeline progress.

November 14, 2023
·
9 min read
Business

Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the third quarter 2023.

November 14, 2023
·
17 min read
Business

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update

Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS) today reported financial results and operating highlights for the third quarter and nine months ended September 30, 2023.

November 14, 2023
·
14 min read
Business

Reviva Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”) today reported financial results for the third quarter ended September 30, 2023 and summarized recent business highlights.

November 14, 2023
·
10 min read
Genetown

Solid Biosciences Announces IND Clearance by FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

Solid Biosciences Inc. (Nasdaq: SLDB) today announced that it has received U.S. Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for SGT-003, the company’s next-generation Duchenne Muscular Dystrophy (Duchenne) gene therapy candidate.

November 14, 2023
·
6 min read
Business

Miromatrix Reports Third Quarter 2023 Results

Miromatrix Medical Inc. (Nasdaq: MIRO) (the “Company”), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today reported third quarter 2023 financial results.

November 14, 2023
·
10 min read
Business

Kodiak Sciences Announces Third Quarter 2023 Financial Results and Recent Business Highlights

Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended September 30, 2023.

November 14, 2023
·
10 min read
Genetown

TransMedics to Present at the Piper Sandler 35th Annual Healthcare Conference

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX) today announced that members of the management team will participate in a fireside chat at the upcoming Piper Sandler 35th Annual Healthcare Conference in New York.

November 14, 2023
·
1 min read